Endometriosis is a debilitating disease with features of chronic inflammation. Endometriosis
appears to be one of the most common benign gynecological proliferations in …

Endometriosis represents a frequently diagnosed gynecological affliction in the reproductive
timespan of women, defined by symptoms ranging from pelvic pain to infertility. A complex …

BACKGROUND Dienogest is a selective progestin that has been investigated in a clinical
trial programme for the treatment of endometriosis. The current non-inferiority trial compared …

There is still much controversy regarding the epidemiology of endometriosis. The objective
of this work is to conduct a systematic review, and if possible, proceed with a meta-analysis …

OBJECTIVE: To investigate the efficacy and safety of oral dienogest 2mg compared with
placebo in the treatment of endometriosis-associated pelvic pain (EAPP). STUDY DESIGN …

Introduction Chronic pelvic pain (CPP) is one of the most frequent symptoms in women of
reproductive age. This is an enigmatic clinical condition that results from the complex …

BACKGROUND Endometriosis is typically regarded as a premenopausal disease, resolving
after natural or iatrogenic menopause due to declining oestrogen levels. Nonetheless, case …

Objective To evaluate the efficacy and safety of three dose levels of relugolix, a
gonadotropin-releasing hormone receptor antagonist, compared with placebo and …

Endometriosis is a chronic disease primarily affecting women of childbearing age, in which
endometriotic lesions form outside the uterus, typically leading to painful symptoms, fatigue …

Results: The serum level of IL-1β, IL-6, and TNF-α is significantly higher in women with
endometriosis compared to women free of disease, from the control group (mean 10.777 …